Efficacy of immune checkpoint inhibitors for in-transit melanoma

BACKGROUND: The efficacy of immune checkpoint inhibitors (ICI) in metastatic melanoma is well established. However, there are limited data regarding their efficacy in in-transit melanoma (ITM). This study assessed the efficacy of ICI in patients with ITM. METHODS: A retrospective review of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Nan Tie, Emilia, Lai-Kwon, Julia, Rtshiladze, Michael Alexander, Na, Lumine, Bozzi, James, Read, Tavis, Atkinson, Victoria, Au-Yeung, George, Long, Georgina V, McArthur, Grant A, Sandhu, Shahneen, Saw, Robyn, Walpole, Euan, Menzies, Alexander, Smithers, Mark, Gyorki, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223285/
https://www.ncbi.nlm.nih.gov/pubmed/32376722
http://dx.doi.org/10.1136/jitc-2019-000440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223285/
https://www.ncbi.nlm.nih.gov/pubmed/32376722
http://dx.doi.org/10.1136/jitc-2019-000440

Ejemplares similares